Skip to main content
. 2022 Feb 13;17(2):153–176. doi: 10.1016/j.ajps.2022.02.001

Fig. 4.

Fig. 4

Schematic representation of nanomedicine trafficking in the treatment of retinal dystrophic conditions starting from (1) intravitreal injection, (2) diffusion through vitreous fluid, (3) cellular uptake, (4) endosomal escape and (5) interest specific gene editing.